Caitlin Murray is a partner in the firm’s Technology & Life Sciences group. Ms. Murray advises public and private companies across the life sciences industry, including biotechnology, pharmaceutical, and medical device companies. Her practice includes public and private securities offerings, such as venture capital investments and public offerings, mergers and acquisitions, and other complex transactions, as well as general corporate matters. She joined Goodwin in 2010.

Areas of Practice
TÄTIGKEITSFELDER
业务范围

Experience

ERFAHRUNG

工作经历

Ms. Murray works on a wide variety of public and private securities offerings, including venture capital investments and public offerings, mergers and acquisitions, and other complex transactions. Her practice centers on biotechnology, pharmaceutical, and medical device companies and companies in other technology-driven industries. Ms. Murray also represents companies in these sectors in their ongoing corporate matters.

Her recent client representation include:

  • Abide Therapeutics, Inc., in its $430 million collaboration with Merck in the metabolic disease and diabetes fields, and their $50 million agreement with Celgene to discover and develop Abide Therapeutics’ drugs in inflammation and immunology
  • Aerpio Therapeutics in several rounds of venture financing for $60 million to research vascular disease therapies
  • aTyr Pharma Inc.in its $76 million Series E financing
  • Brean Capital, LLC  in Cytosorbents Corp’s (NASDAQ:CTSO) $10 million offering
  • Checkmate Pharmaceuticals, Inc. in its $20 million Series A financing
  • Convergent Dental in its $9 million Series B financing
  • Deciphera Pharmaceuticals in its $52 million Series C financing
  • Foundation Medicine, Inc. in its $106 million initial public offering
  • NABsys in several rounds of venture financing for $40 million to advance its genomic analysis technology
  • Naurex in its $80 million Series C financing to advance NMDA receptor modulators in depression and other central nervous system (CNS) disorders
  • Omthera Pharmaceuticals in its $64 million initial public offering
  • Paydiant, a mobile wallet tech company, in its sale to PayPal
  • Royalty Pharma in its $124 million acquisition of royalty interest in CIMZIA® and MIRCERA®
  • Semma Therapeutics in its $44 million Series A financing and separate collaboration agreement with Novartis to develop stem cell therapies for Type 1 diabetes
  • Stifel Nicolaus Weisel as an underwriter in Argos Therapeutics $41 million initial public offering
  • SmartCells, Inc., a private biotechnology company developing a glucose responsive insulin, in its capital raising and ongoing operations as well as its ultimate sale to Merck & Co. for an upfront cash payment as well as potential clinical development and regulatory milestones in excess of $500 million and royalties
  • Vericel Corporation as an underwriter in Aastrom Biosciences $35 million public follow on offering

Recognition

While in law school, Ms. Murray was an editor of the Washington University Journal of Law and Policy.

In The News

MELDUNGEN

在新闻中

Credentials

WERDEGANG

专业资格

Education

J.D., 2009
Washington University School of Law
B.S., Nuclear Science and Engineering, 2006
Massachusetts Institute of Technology

Admissions

Bar

Massachusetts
Get In Touch
KONTAKT
Get In Touch
联系我们
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Unsere Kunden verlassen sich auf uns für erstklassige Beratungsdienste, beraten über komplexe Transaktionsarbeiten und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Industrie, verwenden wir eine kooperative, interdisziplinäre Ansatz zur Lösung unserer Kunden am schwierigsten Fragen. Um mehr zu erfahren, kontaktieren Sie uns bitte.

客户信赖我们世界一流的咨询服务,希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题,涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息,请与我们联系。

Search Other Lawyers
ANWALTSSUCHE
搜寻其他律师